Evidence map›Paper›PMID 22837038›Full record

ReviewNature neuroscience2012

Cross-talk between neural stem cells and immune cells: the key to better brain repair?

Zaal Kokaia, Gianvito Martino, Michal Schwartz, Olle Lindvall

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03269071 (Neural Stem Cell Transplantation in Multiple Sclerosis Patient), which is not on this map. Cited by 172 papers.

0numbers the graph read from it
0cells of the map it votes in
172citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03269071 phase1completednot on this mapstarted 2017, after this paper: background citation

Neural Stem Cell Transplantation in Multiple Sclerosis Patient: a Phase I Study

TypeinterventionalSponsorIRCCS San RaffaeleRan2017 to 2021Enrolled4ConditionsProgressive Multiple SclerosisArmshuman fetal-derived Neural Stem Cells (hNSCs)
3 · Its place in the literature

Who cites it

172 citing papers in PubMed.

  1. Trial
  2. Observational
  3. Review
  4. Article
  5. Article
  6. Repurposing of Chemokine Antagonists for Combined Phase-Resolved Spinal Cord Injury Treatment.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Therapeutic role of neural stem cells in neurological diseases.Frontiers in bioengineering and biotechnology · 2024
    Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

112 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zaal KokaiaLund Stem Cell Center, University Hospital, Lund, Sweden.
Gianvito Martino
Michal Schwartz
Olle Lindvall

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic or intracerebral delivery of neural stem and progenitor cells (NSPCs) and activation of endogenous NSPCs hold much promise as potential treatments for diseases in the human CNS. Recent studies have shed new light on the interaction between the NSPCs and cells belonging to the innate and adaptive arms of the immune system. According to these studies, the immune cells can be both beneficial and detrimental for cell genesis from grafted and endogenous NSPCs in the CNS, and the NSPCs exert their beneficial effects not only by cell replacement but also by immunomodulation and trophic support. The cross-talk between immune cells and NSPCs and their progeny seems to determine both the efficacy of endogenous regenerative responses and the mechanism of action as well as the fate and functional integration of grafted NSPCs. Better understanding of the dialog between NSPCs and innate and adaptive immune cells is crucial for further development of effective strategies for CNS repair.

Indexed as

Cell CommunicationNeuroimmunomodulationStem Cell TransplantationAnimalsBrainHumansImmune SystemNerve RegenerationNeural Stem Cells

Identifiers

PMID22837038

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.